How BPC-157 Works: Mechanism of Action in Peptide Research
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide composed of 15 amino acids. It is a partial sequence isolated from a larger protein — BPC — found in human gastric juice. Because it originates from a naturally protective compartment of the body, researchers have investigated its stability, oral bioavailability, and reparative effects across a range of preclinical models.
Amino acid sequence
The peptide's structure is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. This sequence appears unusually stable in gastric acid and aqueous solution, which is one of the reasons it has drawn continued attention in research contexts.
Proposed mechanisms of action
Published preclinical literature suggests several overlapping mechanisms by which BPC-157 may exert its effects:
- Angiogenesis and VEGFR2 signaling. Studies report upregulation of VEGFR2 (vascular endothelial growth factor receptor 2), which drives the formation of new blood vessels and may accelerate tissue perfusion at injury sites.
- Nitric oxide (NO) system modulation. BPC-157 appears to influence the endothelial NO pathway, which is involved in vasodilation, platelet function, and cytoprotection.
- Growth hormone receptor upregulation. Preclinical work suggests BPC-157 may increase expression of the growth hormone receptor in tendon fibroblasts, potentially amplifying local reparative signaling.
- Gut-brain axis interaction. Because BPC-157 originates from gastric juice, several research groups have examined its effect on dopaminergic and serotonergic pathways in animal models.
Research areas
Preclinical studies have looked at BPC-157 in the context of tendon and ligament healing, muscle-crush injury, gastric ulceration, inflammatory bowel models, and endothelial protection. It's important to note that these are animal or in-vitro findings — no data here should be interpreted as clinical guidance.
Stability and handling
BPC-157 is generally supplied as a lyophilized powder and reconstituted with bacteriostatic water for laboratory workflows. Cold-chain storage is standard for maintaining peptide integrity, and reconstituted material is typically kept refrigerated for short-term research use.
Summary
BPC-157 remains one of the most studied research peptides in preclinical reparative literature. Its proposed mechanisms — angiogenic upregulation, NO modulation, and growth factor signaling — offer a coherent picture, though human data remains limited. All BPC-157 sold by Engineered Genetics is intended strictly for laboratory research and is not for human consumption.